News
New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline: Basel Saturday, May 17, 2025, 11:00 Hrs [IST] Novartis will present data from ...
After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.
22h
Zacks Investment Research on MSNIncyte Gets FDA Approval for Zynyz in New Cancer IndicationIncyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results